OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
María Orietta Borghi, Mauro Bombaci, Caterina Bodio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
Robert Root‐Bernstein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3001-3001
Open Access | Times Cited: 20

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
Pavlina Spiliopoulou, Helena J. Janse van Rensburg, Lisa Avery, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Double-Positive Anti–Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients
Julie Anne Ting, Elena-Bianca Barbir, Susanna A. McRae, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access | Times Cited: 6

Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination: A Case Report
Annika Kits, Mattia Russel Pantalone, Christopher Illies, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2046-2046
Open Access | Times Cited: 9

Preliminary Study on the Restoration of the Phospholipid Profile in Serum from Patients with COVID-19 by Treatment with Vitamin E
María Elena Soto, Linaloe Manzano-Pech, Verónica Guarner‐Lans, et al.
(2024)
Open Access | Times Cited: 1

Comparison of anti-phospholipid antibody titers before and after SARS-CoV-2 mRNA vaccination in hospital staff
Michi Hisano, Naho Morisaki, Makiko Sampei, et al.
Vaccine X (2024) Vol. 20, pp. 100539-100539
Open Access | Times Cited: 1

Anti-phospholipid autoantibodies in human diseases
Rencai Qin, Haiqi Wu, Hui Guan, et al.
Clinical Immunology (2023) Vol. 256, pp. 109803-109803
Closed Access | Times Cited: 4

Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies
Robert Root‐Bernstein, Jack Huber, Alison Ziehl
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11500-11500
Open Access | Times Cited: 6

Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2
Manca Ogrič, Polona Žigon, Snežna Sodin‐Šemrl, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 211-211
Open Access | Times Cited: 6

New approaches to vaccines for autoimmunity
Vivek P. Chavda, Niva Rani Gogoi, Yesha Shah, et al.
Elsevier eBooks (2024), pp. 391-414
Closed Access

Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection
Dorit Blickstein, Marina Izak, Talia Filipovich‐Rimon, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 7, pp. 517-522
Closed Access | Times Cited: 1

Immune-mediated diseases after vaccinations with AZD1222, BNT-162b2, &/or mRNA-1273: An observational investigation of 78 patients
Tao-Shen Ou, Yi-Syuan Sun, Chien‐Chih Lai, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111455-111455
Closed Access | Times Cited: 1

Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients
Matthijs P. Raadsen, Chantal Visser, A. H. Ayesha Lavell, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1851-1851
Open Access

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
Pavlina Spiliopoulou, Helena J. Janse van Rensburg, Lisa Avery, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 15 citing articles:

Your Privacy